117 related articles for article (PubMed ID: 7787209)
1. Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes.
Basso D; Plebani M; Fogar P; Panozzo MP; Meggiato T; De Paoli M; Del Favero G
Int J Clin Lab Res; 1995; 25(1):40-3. PubMed ID: 7787209
[TBL] [Abstract][Full Text] [Related]
2. C-peptide pattern in patients with pancreatic cancer.
Fogar P; Basso D; Panozzo MP; Del Favero G; Briani G; Fabris C; D'Angeli F; Meggiato T; Ferrara C; Plebani M
Anticancer Res; 1993; 13(6B):2577-80. PubMed ID: 8135497
[TBL] [Abstract][Full Text] [Related]
3. Serum and tissue level of insulin-like growth factor-I (IGF-I) and IGF-I binding proteins as an index of pancreatitis and pancreatic cancer.
Karna E; Surazynski A; Orłowski K; Łaszkiewicz J; Puchalski Z; Nawrat P; Pałka J
Int J Exp Pathol; 2002 Oct; 83(5):239-45. PubMed ID: 12641820
[TBL] [Abstract][Full Text] [Related]
4. Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer.
Fogar P; Basso D; Pasquali C; Piva MG; Brigato L; De Paoli M; Galeotti F; Corsini A; Plebani M
Clin Chim Acta; 1998 Oct; 277(2):181-9. PubMed ID: 9853701
[TBL] [Abstract][Full Text] [Related]
5. Serum growth factors in patients with pancreatic cancer.
Meggiato T; Plebani M; Basso D; Panozzo MP; Del Favero G
Tumour Biol; 1999; 20(2):65-71. PubMed ID: 10050105
[TBL] [Abstract][Full Text] [Related]
6. Diabetes associated with pancreatic diseases.
Meier JJ; Giese A
Curr Opin Gastroenterol; 2015 Sep; 31(5):400-6. PubMed ID: 26125315
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor, insulin like growth factor-1 and inflammatory cytokine responses to continuous and intermittent exercise in patients with type 1 diabetes.
Żebrowska A; Hall B; Maszczyk A; Banaś R; Urban J
Diabetes Res Clin Pract; 2018 Oct; 144():126-136. PubMed ID: 30179684
[TBL] [Abstract][Full Text] [Related]
8. Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies.
Mao C; Domenico DR; Kim K; Hanson DJ; Howard JM
Arch Surg; 1995 Feb; 130(2):125-34. PubMed ID: 7848081
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, and the risk of pancreatic cancer death.
Lin Y; Tamakoshi A; Kikuchi S; Yagyu K; Obata Y; Ishibashi T; Kawamura T; Inaba Y; Kurosawa M; Motohashi Y; Ohno Y
Int J Cancer; 2004 Jul; 110(4):584-8. PubMed ID: 15122592
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is associated with chronic hyperglycemia and insulin resistance in patients after acute pancreatitis.
Gillies N; Pendharkar SA; Asrani VM; Mathew J; Windsor JA; Petrov MS
Pancreatology; 2016; 16(5):748-55. PubMed ID: 27401909
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of angiogenesis-related molecules in patients with pancreatic cancer.
Sakamoto H; Kimura H; Sekijima M; Matsumoto K; Arao T; Chikugo T; Yamada Y; Kitano M; Ito A; Takeyama Y; Kudo M; Nishio K
Jpn J Clin Oncol; 2012 Feb; 42(2):105-12. PubMed ID: 22167663
[TBL] [Abstract][Full Text] [Related]
12. Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis.
Sharma A; Smyrk TC; Levy MJ; Topazian MA; Chari ST
Gastroenterology; 2018 Aug; 155(2):490-500.e2. PubMed ID: 29723506
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells.
Wolf M; Böhm S; Brand M; Kreymann G
Eur J Endocrinol; 1996 Dec; 135(6):729-37. PubMed ID: 9025720
[TBL] [Abstract][Full Text] [Related]
14. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
15. Hyperglycemia promotes insulin-independent ovarian tumor growth.
Kellenberger LD; Petrik J
Gynecol Oncol; 2018 May; 149(2):361-370. PubMed ID: 29458977
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
[TBL] [Abstract][Full Text] [Related]
17. Islet hormone secretion in pancreatic cancer patients with diabetes.
Permert J; Larsson J; Fruin AB; Tatemoto K; Herrington MK; von Schenck H; Adrian TE
Pancreas; 1997 Jul; 15(1):60-8. PubMed ID: 9211494
[TBL] [Abstract][Full Text] [Related]
18. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
Biadgo B; Abebe M
Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathways.
Cao L; Chen X; Xiao X; Ma Q; Li W
Int J Oncol; 2016 Aug; 49(2):735-43. PubMed ID: 27278736
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
